Tracks how medical cannabis affects pain, sleep, anxiety and depression
Observes patients using medical cannabis for pain, epilepsy, sleep, anxiety or depression.
Plain-language title generated from the registry record
Registry title: Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)
Key facts
- Where
- Toronto, CanadaSee the site
Where in Canada
- Toronto General Hospital, UHNToronto, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Health Network, Toronto
- Trial code
- NCT04526093
- Record updated
- 22 July 2026
- Original description
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.Read full original descriptionShow less
MC-RWE : Real World Evidence in Patient-Reported Outcomes for Medical Cannabis: A Prospective Observational Study
This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.
Inclusion: Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent; Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression; Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study.
Exclusion: Concomitant use of illicit drugs; Concomitant use of recreational cannabis.